Advertisement

Advertisement

Expert’s Corner

Advertisement

Advertisement



Sep
19
Today In Oncology
Cost of Treatment, Prior Authorization of Treatment Plans May Cause Barriers to Care
FDA Grants Approval to Lenvatinib/Pembrolizumab in Advanced Endometrial Cancer, Announces Project Orbis
Olaparib Improves Outcomes in Ovarian Cancer
Does PTSD Increase the Risk of Developing Ovarian Cancer?
Does the Addition of Bevacizumab to Erlotinib in Advanced EGFR-Mutant NSCLC Improve PFS?
View More 
Advertisement
Most Read Stories
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
WCLC 2019: KEYNOTE-024 Survival Update Shows Benefit With Pembrolizumab vs Chemotherapy in Advanced NSCLC
Meta-analysis of Chemotherapy and Hormonal Treatments for Postmenopausal Women With Metastatic Breast Cancer
ASTRO 2019: Patterns of Disease Progression in Patients With Unresectable Stage III NSCLC: Analysis of the PACIFIC Trial
Management of HER2-Positive Breast Cancer: Business as Usual?
View More 
Most Viewed Videos
Cristina Merkhofer, MD, MHS, on NSCLC: Survival Impact of Taking Part in a Clinical Trial
Grace C. Hillyer, EdD, MPH, on Enrolling Patients in Clinical Trials: Improving Clinician-Patient Communication
Nadine Housri, MD, on Online Tumor Boards: A New Resource for Practicing Oncologists
Elena Martinez, PhD, MPH, on Diversity in Precision Oncology
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
View More 
© 2019 HSP News Service, L.L.C.